Gem Aromatics Ltd Quarterly Results, Profit & Loss, Balance Sheet (GEMAROMA) | Stocksigma

Gem Aromatics Ltd (GEMAROMA) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Gem Aromatics Ltd reported sales of ₹104 Cr, operating profit of ₹7.87 Cr (OPM 7.57%) and net profit of ₹-7.02 Cr for the quarter ended Sep 2026. Figures in ₹ crore, consolidated where available.

GEMAROMA quarterly results (₹ Cr)
Metric	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	96.84	202.22	87.63	89.53	78.9	110.41	98.85	104
Expenses	83.81	156.35	72.77	86.48	71.88	94.7	95.54	96.13
Operating Profit	13.03	45.87	14.86	3.05	7.02	15.71	3.31	7.87
OPM	13.46%	22.68%	16.96%	3.41%	8.9%	14.23%	3.35%	7.57%
Other Income	0.5	-0.43	1.27	0.98	-1.66	0.3	0.16	0.13
Interest	2.22	3.44	3.52	3.5	2.58	2.97	2.88	4.74
Depreciation	1.89	1.92	1.82	3.05	8.71	9.01	9.13	9.53
Profit before tax	9.42	40.08	10.79	-2.52	-5.93	4.03	-8.54	-6.27
Tax	20.81%	31.11%	25.95%	2.38%	-15.85%	74.94%	-7.85%	11.8%
Net Profit	7.46	27.6	7.98	-2.58	-4.99	1.01	-7.87	-7.02
EPS in Rs	1.59	5.89	1.7	-0.49	-0.96	0.19	-1.51	-1.34

GEMAROMA profit & loss, annual (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	314	425	452	504	366	392
Expenses	265	359	374	415	326	358
Operating Profit	49	66	78	88	41	34
OPM	16%	16%	17%	18%	11%	9%
Other Income	3	0	2	1	1	-1
Interest	3	6	6	8	13	13
Depreciation	4	5	6	7	23	36
Profit before tax	44	56	68	74	6	-17
Tax	30%	20%	26%	28%	78%	-
Net Profit	31	45	50	53	1	-19
EPS in Rs	6.68	9.57	10.69	11.39	0.27	-3.62
Dividend Payout	0%	0%	0%	0%	0%	-

GEMAROMA balance sheet (₹ Cr)
Metric	Mar 2024	Mar 2025	Sep 2025	Mar 2026	Sep 2026
Equity Capital	9	9	10	10	10
Reserves	221	275	445	439	424
Borrowings	112	227	144	152	261
Other Liabilities	26	26	59	40	40
Total Liabilities	369	536	658	642	736
Fixed Assets	50	54	217	253	255
CWIP	30	126	25	6	0
Investments	0	0	0	0	0
Other Assets	289	356	416	382	480
Total Assets	369	536	658	642	736

GEMAROMA cash flows (₹ Cr)
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-5	15	40	-25	30
Cash from Investing Activity	-15	-18	-50	-92	-102
Cash from Financing Activity	18	6	15	105	78
Net Cash Flow	-2	4	5	-13	5
Free Cash Flow	-19	1	1	-130	-65
CFO/OP	12%	50%	71%	0%	100%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit	12	50	71	0	100

GEMAROMA ratios
Metric	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	46	68	37	102	76
Inventory Days	206	164	187	160	309
Days Payable	27	24	20	16	25
Cash Conversion Cycle	225	208	203	246	360
Working Capital Days	110	102	121	115	179
ROCE	25%	25%	24%	19%	3%